LOUISVILLE, Ky. (WDRB) -- Indiana Attorney General Todd Rokita is suing two pharmaceutical companies, claiming they are putting profits over patients, when it comes to EpiPens.
The lawsuit filed Thursday in Marion County Superior Court accuses Mylan and Pfizer of conspiring to raise the price of EpiPens by more than 600%.
EpiPens are a life-saving tool that inject adrenaline into patients during severe allergic reactions.
"Many Indiana residents rely on these medications to stay alive," Rokita said in a news release. "Hoosiers deserve to know that the prices they pay for epinephrine arise from free and fair competition."
The lawsuit claims the companies and their subsidiaries violated the Indiana Deceptive Consumer Sales Act, the Indiana Antitrust Act, and the Medicaid False Claims Act by continually increasing the price of EpiPens and paying pharmacy benefit managers to exclude competition.
It also accuses the companies of paying doctors to endorse a 2-pak of the EpiPen and claim it is medically necessary, allowing the companies to stop selling individual EpiPens.
Related Stories:
- Pharmacists, lawmakers call for transparency in prescription drug costs as small businesses struggle
- US health officials approve generic alternative to EpiPen
- EpiPen to pay more than $12 million to settle Kentucky lawsuit
- Louisville doctors concerned about high EpiPen price
Copyright 2025 WDRB Media. All Rights Reserved.
